KIAA0748 Activators encompass a diverse array of chemical compounds that indirectly invoke the functional activity of KIAA0748 through a variety of signaling pathways. Compounds like Forskolin, 8-Bromo-cAMP, IBMX, Dibutyryl-cAMP, and Rolipram exert their effects by increasing intracellular levels of cAMP, an essential secondary messenger that activates Protein Kinase A (PKA). Once activated, PKA may phosphorylate KIAA0748, which is presumed to enhance its activity within cellular processes. Additionally, Ionomycin and A23187, as calcium ionophores, elevate intracellular calcium levels, a critical factor that can initiate a cascade of calcium-dependent phosphorylation events, possibly including the activation of KIAA0748. In a similar vein, Thapsigargin raises cytosolic calcium by inhibiting the SERCA pump, again potentially leading to the activation of KIAA0748 throughcalcium-dependent pathways.
In parallel, the activation of protein kinase C (PKC) by Phorbol 12-myristate 13-acetate (PMA), a compound mimicking diacylglycerol, represents another mechanism through which KIAA0748 may be activated, as PKC-mediated phosphorylation events are pivotal in numerous signaling cascades that KIAA0748 may partake in. Further enhancing the activity of KIAA0748, Sphingosine-1-phosphate, a signaling lipid, can activate its receptors and instigate downstream kinase signaling potentially influencing KIAA0748's role. Calmodulin, activated by increases in intracellular calcium, modulates a spectrum of kinases and phosphatases that may, in turn, affect the activity of KIAA0748.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. Activated PKA can subsequently phosphorylate KIAA0748, thereby increasing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases, which could then enhance the activity of KIAA0748 by phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can lead to phosphorylation of proteins in pathways where KIAA0748 is involved, potentially enhancing the functional activity of KIAA0748. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. Increased cAMP levels can activate PKA, thus potentially enhancing KIAA0748 activity through phosphorylation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore elevating intracellular calcium concentrations, which could activate calcium-dependent kinases and potentially enhance KIAA0748 activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is another cAMP analog that permeates cell membranes and activates PKA. PKA can then enhance the activity of KIAA0748 through phosphorylation. | ||||||
Calmodulin (human), (recombinant) | 73298-54-1 | sc-471287 | 1 mg | $300.00 | ||
Calmodulin, activated by calcium, can interact with and activate various kinases and phosphatases. These activated enzymes could then modulate the activity of KIAA0748 indirectly. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) is a bioactive lipid that activates S1P receptors, triggering downstream kinase signaling pathways that could converge on the modulation of KIAA0748 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to an increase in cAMP levels. Elevated cAMP can activate PKA, which may then phosphorylate KIAA0748 to enhance its activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium, which can activate calcium-dependent signaling pathways, potentially leading to the activation of KIAA0748. | ||||||